These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10853669)

  • 41. Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    South MS; Case BL; Wood RS; Jones DE; Hayes MJ; Girard TJ; Lachance RM; Nicholson NS; Clare M; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; Parlow JJ
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2319-25. PubMed ID: 12824026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC; Jiang X
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin.
    Whitlow M; Arnaiz DO; Buckman BO; Davey DD; Griedel B; Guilford WJ; Koovakkat SK; Liang A; Mohan R; Phillips GB; Seto M; Shaw KJ; Xu W; Zhao Z; Light DR; Morrissey MM
    Acta Crystallogr D Biol Crystallogr; 1999 Aug; 55(Pt 8):1395-404. PubMed ID: 10417407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymer-assisted solution-phase (PASP) parallel synthesis of an alpha-ketothiazole library as tissue factor VIIa inhibitors.
    South MS; Dice TA; Girard TJ; Lachance RM; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; Parlow JJ
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2363-7. PubMed ID: 12824035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.
    Lazarova TI; Jin L; Rynkiewicz M; Gorga JC; Bibbins F; Meyers HV; Babine R; Strickler J
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5022-7. PubMed ID: 16876411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors.
    Rewinkel JB; Lucas H; van Galen PJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
    Bioorg Med Chem Lett; 1999 Mar; 9(5):685-90. PubMed ID: 10201829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.
    Dudley DA; Bunker AM; Chi L; Cody WL; Holland DR; Ignasiak DP; Janiczek-Dolphin N; McClanahan TB; Mertz TE; Narasimhan LS; Rapundalo ST; Trautschold JA; Van Huis CA; Edmunds JJ
    J Med Chem; 2000 Nov; 43(22):4063-70. PubMed ID: 11063603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1,2-Dibenzamidobenzene inhibitors of human factor Xa.
    Herron DK; Goodson T; Wiley MR; Weir LC; Kyle JA; Yee YK; Tebbe AL; Tinsley JM; Mendel D; Masters JJ; Franciskovich JB; Sawyer JS; Beight DW; Ratz AM; Milot G; Hall SE; Klimkowski VJ; Wikel JH; Eastwood BJ; Towner RD; Gifford-Moore DS; Craft TJ; Smith GF
    J Med Chem; 2000 Mar; 43(5):859-72. PubMed ID: 10715153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of Isosteviol derivatives as FXa inhibitors.
    Shi Y; Pan BW; Li WC; Wang Q; Wu Q; Pan M; Fu HZ
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126585. PubMed ID: 31859158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
    Shi Y; O'Connor SP; Sitkoff D; Zhang J; Shi M; Bisaha SN; Wang Y; Li C; Ruan Z; Lawrence RM; Klei HE; Kish K; Liu EC; Seiler SM; Schweizer L; Steinbacher TE; Schumacher WA; Robl JA; Macor JE; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7516-21. PubMed ID: 22041058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.
    Maduskuie TP; McNamara KJ; Ru Y; Knabb RM; Stouten PF
    J Med Chem; 1998 Jan; 41(1):53-62. PubMed ID: 9438022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
    Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
    J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.
    Katakura S; Nagahara T; Hara T; Iwamoto M
    Biochem Biophys Res Commun; 1993 Dec; 197(2):965-72. PubMed ID: 8267636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dibasic (amidinoaryl)propanoic acid derivatives as novel blood coagulation factor Xa inhibitors.
    Nagahara T; Yokoyama Y; Inamura K; Katakura S; Komoriya S; Yamaguchi H; Hara T; Iwamoto M
    J Med Chem; 1994 Apr; 37(8):1200-7. PubMed ID: 8164262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and evaluation of anthranilamide-based derivatives as FXa inhibitors.
    Huang C; Wang W; Li Y; Zhang S; Meng F; Xu W; Yuan J; Chen L
    Oncotarget; 2017 Jun; 8(23):37186-37199. PubMed ID: 28415603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor Xa.
    Klein SI; Czekaj M; Gardner CJ; Guertin KR; Cheney DL; Spada AP; Bolton SA; Brown K; Colussi D; Heran CL; Morgan SR; Leadley RJ; Dunwiddie CT; Perrone MH; Chu V
    J Med Chem; 1998 Feb; 41(4):437-50. PubMed ID: 9484495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.
    Hasegawa M; Nishigaki N; Washio Y; Kano K; Harris PA; Sato H; Mori I; West RI; Shibahara M; Toyoda H; Wang L; Nolte RT; Veal JM; Cheung M
    J Med Chem; 2007 Sep; 50(18):4453-70. PubMed ID: 17676829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process.
    Geratz JD; Cheng MC; Tidwell RR
    J Med Chem; 1975 May; 18(5):477-81. PubMed ID: 1171238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.
    Willardsen JA; Dudley DA; Cody WL; Chi L; McClanahan TB; Mertz TE; Potoczak RE; Narasimhan LS; Holland DR; Rapundalo ST; Edmunds JJ
    J Med Chem; 2004 Jul; 47(16):4089-99. PubMed ID: 15267248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.